Jefferies Group LLC Myriad Genetics Inc Transaction History

Jefferies Group LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $2.29 Million - $2.95 Million	85,131 New	85,131 $2.83 Million
Q3 2018 Nov 14, 2018	SELL	$37.57 - $50.34 $251,042 - $336,371	-6,682 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$27.75 - $40.17 $14,180 - $20,526	-511 Reduced 7.1%	6,682 $250,000
Q1 2018 May 15, 2018	SELL	$28.83 - $41.01 $69,941 - $99,490	-2,426 Reduced 25.22%	7,193 $213,000
Q4 2017 Feb 14, 2018	BUY	$28.45 - $37.14 $273,660 - $357,249	9,619	9,619 $330,000

238

92.7M

117K

113K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.77B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.